JP2011530701A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530701A5
JP2011530701A5 JP2011522287A JP2011522287A JP2011530701A5 JP 2011530701 A5 JP2011530701 A5 JP 2011530701A5 JP 2011522287 A JP2011522287 A JP 2011522287A JP 2011522287 A JP2011522287 A JP 2011522287A JP 2011530701 A5 JP2011530701 A5 JP 2011530701A5
Authority
JP
Japan
Prior art keywords
angiotensin
sample
amount
ions
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530701A (ja
JP5373902B2 (ja
Filing date
Publication date
Priority claimed from US12/189,092 external-priority patent/US7834313B2/en
Application filed filed Critical
Publication of JP2011530701A publication Critical patent/JP2011530701A/ja
Publication of JP2011530701A5 publication Critical patent/JP2011530701A5/ja
Application granted granted Critical
Publication of JP5373902B2 publication Critical patent/JP5373902B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522287A 2008-08-08 2009-08-07 血漿レニンの質量分析法 Active JP5373902B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/189,092 US7834313B2 (en) 2008-08-08 2008-08-08 Mass spectrometry assay for plasma-renin
US12/189,092 2008-08-08
PCT/US2009/053189 WO2010017499A1 (en) 2008-08-08 2009-08-07 Mass spectrometry assay for plasma-renin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013194007A Division JP5855062B2 (ja) 2008-08-08 2013-09-19 血漿レニンの質量分析法

Publications (3)

Publication Number Publication Date
JP2011530701A JP2011530701A (ja) 2011-12-22
JP2011530701A5 true JP2011530701A5 (enExample) 2012-09-27
JP5373902B2 JP5373902B2 (ja) 2013-12-18

Family

ID=41652003

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011522287A Active JP5373902B2 (ja) 2008-08-08 2009-08-07 血漿レニンの質量分析法
JP2013194007A Active JP5855062B2 (ja) 2008-08-08 2013-09-19 血漿レニンの質量分析法
JP2015239495A Active JP6110469B2 (ja) 2008-08-08 2015-12-08 血漿レニンの質量分析法
JP2017044480A Active JP6396525B2 (ja) 2008-08-08 2017-03-09 血漿レニンの質量分析法
JP2018159953A Active JP7154887B2 (ja) 2008-08-08 2018-08-29 血漿レニンの質量分析法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2013194007A Active JP5855062B2 (ja) 2008-08-08 2013-09-19 血漿レニンの質量分析法
JP2015239495A Active JP6110469B2 (ja) 2008-08-08 2015-12-08 血漿レニンの質量分析法
JP2017044480A Active JP6396525B2 (ja) 2008-08-08 2017-03-09 血漿レニンの質量分析法
JP2018159953A Active JP7154887B2 (ja) 2008-08-08 2018-08-29 血漿レニンの質量分析法

Country Status (7)

Country Link
US (1) US7834313B2 (enExample)
EP (2) EP2565905B1 (enExample)
JP (5) JP5373902B2 (enExample)
CN (2) CN102112857B (enExample)
BR (1) BRPI0917497B8 (enExample)
CA (1) CA2732109C (enExample)
WO (1) WO2010017499A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2721049B2 (ja) 1991-05-13 1998-03-04 株式会社クボタ 包装装置
JP2771344B2 (ja) 1991-05-14 1998-07-02 株式会社クボタ 包装装置
EP2181325A1 (en) * 2007-08-24 2010-05-05 Millipore Corporation System and method for diversion of a liquid chromatography eluant
US8106351B2 (en) * 2008-08-08 2012-01-31 Quest Diagnostics Investments Incorporated Mass spectrometry assay for plasma-renin
US7834313B2 (en) * 2008-08-08 2010-11-16 Quest Diagnostics Investments Incorporated Mass spectrometry assay for plasma-renin
EP2384437B1 (en) * 2008-12-24 2018-12-12 Quest Diagnostics Investments Incorporated Mass spectrometry assay for pregnenolone and 17-hydroxypregnenolone
JP5675442B2 (ja) * 2011-03-04 2015-02-25 株式会社日立ハイテクノロジーズ 質量分析方法及び質量分析装置
JP6034389B2 (ja) * 2011-10-13 2016-11-30 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 推薦システムからの要求の評価の自動生成
EP2859343B1 (en) * 2012-06-06 2019-10-23 Attoquant Diagnostics GmbH Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
AU2015259294A1 (en) * 2014-05-12 2016-12-01 Quest Diagnostics Investments Llc Quantitation of tamoxifen and metabolites thereof by mass spectrometry
JP6198693B2 (ja) * 2014-08-06 2017-09-20 三菱電機株式会社 リモコン装置
CA3041724C (en) * 2016-11-17 2022-05-31 Laboratory Corporation Of America Holdings Methods and systems for measuring plasma renin activity
JP7067758B2 (ja) * 2017-06-30 2022-05-16 国立大学法人 新潟大学 試料中のアンジオテンシンペプチドの量を測定するための方法及びアンジオテンシンペプチドの定量キット
CN110243917A (zh) * 2018-03-09 2019-09-17 中国科学院天津工业生物技术研究所 一种快速检测小分子化合物的方法
CN112189137A (zh) * 2018-03-16 2021-01-05 奎斯特诊断投资有限公司 多重患者样品中的睾丸酮的质谱法测定
CN112014509A (zh) * 2020-09-03 2020-12-01 复旦大学附属中山医院 同步测定样品中血管紧张素i和醛固酮的方法
CN117647606B (zh) * 2024-01-30 2024-09-03 西湖欧米(杭州)生物科技有限公司 适于lc-ms/ms能同时检测多种蛋白的试剂盒

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919407A (en) * 1973-11-28 1975-11-11 De Castro Aurora L Fernandez Method for quantitative determination of renin activity in blood
US3984532A (en) 1973-11-28 1976-10-05 Fernandez De Castro Aurora L Method for quantitative determination of renin activity in blood employing phenyl methyl sulfonyl fluoride and polyethylene glycol
US4022577A (en) 1976-03-12 1977-05-10 The University Of Virginia Automated radioimmunoassay
US4112064A (en) 1977-02-22 1978-09-05 Hoffmann-La Roche Inc. Stabilized angiotensin I solutions
JPS63217272A (ja) * 1987-03-06 1988-09-09 Daiichi Rajio Isotope Kenkyusho:Kk 活性型レニン測定法
GB2267385B (en) * 1992-05-29 1995-12-13 Finnigan Corp Method of detecting the ions in an ion trap mass spectrometer
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
EP0700521B1 (en) * 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5572025A (en) 1995-05-25 1996-11-05 The Johns Hopkins University, School Of Medicine Method and apparatus for scanning an ion trap mass spectrometer in the resonance ejection mode
JPH09119916A (ja) * 1995-10-24 1997-05-06 Sumika Bunseki Center:Kk 微量化合物の定量分析方法
US5772874A (en) 1995-11-02 1998-06-30 Cohesive Technologies, Inc. High performance liquid chromatography method and apparatus
ES2140209T3 (es) 1996-01-19 2000-02-16 Cohesive Tech Inc Procedimiento y dispositivo de cromatografia de liquidos de alto rendimiento.
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
US6107626A (en) * 1997-10-14 2000-08-22 The University Of Washington Device and method for forming ions
US5869832A (en) * 1997-10-14 1999-02-09 University Of Washington Device and method for forming ions
AU2463299A (en) 1998-01-23 1999-08-09 Analytica Of Branford, Inc. Mass spectrometry from surfaces
US7300753B2 (en) 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US6495338B1 (en) * 1998-09-04 2002-12-17 University Of Utah Research Foundation Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
AU2001236726A1 (en) * 2000-02-08 2001-08-20 The Regents Of The University Of Michigan Protein separation and display
JP2004532392A (ja) * 2001-02-20 2004-10-21 アドヴィオン バイオサイエンシィズ インコーポレイテッド 親和性吸着剤を有するマイクロチップ電子噴霧装置およびカラムならびにそれらの使用法
JP3865129B2 (ja) * 2002-08-19 2007-01-10 株式会社島津製作所 Ｌｃ−ｍｓ分析方法及びその移動相
US6977143B1 (en) 2003-09-08 2005-12-20 Quest Diagnostics Investments Incorporated Determination of testosterone by mass spectrometry
JP4512589B2 (ja) * 2004-02-26 2010-07-28 独立行政法人科学技術振興機構 表面加工が施された試料保持面を有する試料ターゲットおよびその製造方法、並びに当該試料ターゲットを用いた質量分析装置
CA2569137A1 (en) * 2004-06-07 2005-12-22 Nastech Pharmaceutical Company Inc. Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
EP1619503A1 (en) * 2004-07-15 2006-01-25 BioVisioN AG Use of standards for monitoring alterations of peptide and protein samples
US7332296B2 (en) 2004-12-02 2008-02-19 Wright State University Screening assay for enzymes involved in pathophysiology using SELDI-TOF mass spectrometry
JP2006180813A (ja) * 2004-12-28 2006-07-13 Daiichi Fine Chemical Co Ltd アミノペプチダーゼｏおよびその利用
DE602007003832D1 (de) * 2006-06-06 2010-01-28 Roche Diagnostics Gmbh Gebrauchsfertiges sammelgefäss für vollblut
JP2008007482A (ja) * 2006-06-30 2008-01-17 Univ Of Miyazaki 昇圧作用を有する新規ポリペプチド
JP5276993B2 (ja) * 2007-01-31 2013-08-28 中外製薬株式会社 低分子量ペプチドの高感度定量方法
WO2009036336A2 (en) * 2007-09-12 2009-03-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomarkers for motor neuron disease
US7834313B2 (en) * 2008-08-08 2010-11-16 Quest Diagnostics Investments Incorporated Mass spectrometry assay for plasma-renin

Similar Documents

Publication Publication Date Title
JP2011530701A5 (enExample)
Ciminiello et al. LC-MS of palytoxin and its analogues: State of the art and future perspectives
Bostanci et al. Metaproteome and metabolome of oral microbial communities
Zhang et al. Simultaneous determination of 12 illicit drugs in whole blood and urine by solid phase extraction and UPLC–MS/MS
JP2011505013A5 (enExample)
JP2011504596A5 (enExample)
JP2018077253A5 (enExample)
WO2012003478A3 (en) Detecting targets using mass tags and mass spectrometry
WO2008148557A3 (en) Sample holder device for ionization chambers for mass spectometry
Liang et al. Effect of mobile phase additives on qualitative and quantitative analysis of ginsenosides by liquid chromatography hybrid quadrupole-time of flight mass spectrometry
EP2565905A3 (en) Mass spectrometry assay for plasma-renin
Paek et al. Hydrophilic interaction liquid chromatography–tandem mass spectrometry for the determination of levosulpiride in human plasma
JP2017516104A5 (enExample)
Lee et al. Determination of metoclopramide in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry
Cao et al. Development of an HPLC–MS/MS method for the simultaneous analysis of six kinds of parabens in food
Rasheed et al. Analytical Separation and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in Levosalbutamol Respules Formulation
Selvan et al. Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization–tandem mass spectrometry and its application to pharmacokinetic study
WO2013184995A8 (en) Methods and apparatus for performing mass spectrometry
Fan et al. Pharmacokinetic studies of ginkgolide K in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry
Ramesh et al. LC–MS/MS characterization of forced degradation products of zofenopril
Kim et al. Determination of dapoxetine in rat plasma by ultra-performance liquid chromatography–tandem mass spectrometry
Medina-Pérez et al. Multiply charged ion profiles in the UHPLC-HRMS analysis of palytoxin analogues from Ostreopsis cf. ovata blooms
Rohith et al. A validated chiral liquid chromatographic method for the enantiomeric separation of dapoxetine hydrochloride
JP2012052940A5 (enExample)
Lee et al. Simple quantitation of formoterol and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human urine by liquid chromatography-tandem mass spectrometry in doping control